BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27086544)

  • 1. Receptor Tyrosine Kinase MET Interactome and Neurodevelopmental Disorder Partners at the Developing Synapse.
    Xie Z; Li J; Baker J; Eagleson KL; Coba MP; Levitt P
    Biol Psychiatry; 2016 Dec; 80(12):933-942. PubMed ID: 27086544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pleiotropic MET Receptor Network: Circuit Development and the Neural-Medical Interface of Autism.
    Eagleson KL; Xie Z; Levitt P
    Biol Psychiatry; 2017 Mar; 81(5):424-433. PubMed ID: 27837921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte Growth Factor Modulates MET Receptor Tyrosine Kinase and β-Catenin Functional Interactions to Enhance Synapse Formation.
    Xie Z; Eagleson KL; Wu HH; Levitt P
    eNeuro; 2016; 3(4):. PubMed ID: 27595133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct intracellular signaling mediates C-MET regulation of dendritic growth and synaptogenesis.
    Eagleson KL; Lane CJ; McFadyen-Ketchum L; Solak S; Wu HH; Levitt P
    Dev Neurobiol; 2016 Oct; 76(10):1160-81. PubMed ID: 26818605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the Proteome of Developing Neocortical Synaptosomes in the Absence of MET Signaling Revealed by Comparative Proteomics.
    Eagleson KL; Levitt P
    Dev Neurosci; 2023; 45(3):126-138. PubMed ID: 36882009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The autism-associated MET receptor tyrosine kinase engages early neuronal growth mechanism and controls glutamatergic circuits development in the forebrain.
    Peng Y; Lu Z; Li G; Piechowicz M; Anderson M; Uddin Y; Wu J; Qiu S
    Mol Psychiatry; 2016 Jul; 21(7):925-35. PubMed ID: 26728565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MET receptor tyrosine kinase controls dendritic complexity, spine morphogenesis, and glutamatergic synapse maturation in the hippocampus.
    Qiu S; Lu Z; Levitt P
    J Neurosci; 2014 Dec; 34(49):16166-79. PubMed ID: 25471559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative complement control protein CSMD3 dysfunction impairs synaptogenesis and induces neurodevelopmental disorders.
    Song W; Li Q; Wang T; Li Y; Fan T; Zhang J; Wang Q; Pan J; Dong Q; Sun ZS; Wang Y
    Brain Behav Immun; 2022 May; 102():237-250. PubMed ID: 35245678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-delimited signaling of MET receptor tyrosine kinase regulates cortical circuit development and critical period plasticity.
    Chen K; Ma X; Nehme A; Wei J; Cui Y; Cui Y; Yao D; Wu J; Anderson T; Ferguson D; Levitt P; Qiu S
    Mol Psychiatry; 2021 Aug; 26(8):3723-3736. PubMed ID: 31900430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of cortical synapse development and plasticity by MET receptor tyrosine kinase, a genetic risk factor for autism.
    Ma X; Qiu S
    J Neurosci Res; 2020 Nov; 98(11):2115-2129. PubMed ID: 31746037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploinsufficiency in the ANKS1B gene encoding AIDA-1 leads to a neurodevelopmental syndrome.
    Carbonell AU; Cho CH; Tindi JO; Counts PA; Bates JC; Erdjument-Bromage H; Cvejic S; Iaboni A; Kvint I; Rosensaft J; Banne E; Anagnostou E; Neubert TA; Scherer SW; Molholm S; Jordan BA
    Nat Commun; 2019 Aug; 10(1):3529. PubMed ID: 31388001
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Llamosas N; Arora V; Vij R; Kilinc M; Bijoch L; Rojas C; Reich A; Sridharan B; Willems E; Piper DR; Scampavia L; Spicer TP; Miller CA; Holder JL; Rumbaugh G
    J Neurosci; 2020 Oct; 40(41):7980-7994. PubMed ID: 32887745
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensive immunoprofiling of neurodevelopmental disorders suggests three distinct classes based on increased neurogenesis, Th-1 polarization or IL-1 signaling.
    Sreenivas N; Maes M; Padmanabha H; Dharmendra A; Chakkera P; Paul Choudhury S; Abdul F; Mullapudi T; Gowda VK; Berk M; Vijay Sagar Kommu J; Debnath M
    Brain Behav Immun; 2024 Jan; 115():505-516. PubMed ID: 37972879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorin4D Induces Inhibitory Synapse Formation by Rapid Stabilization of Presynaptic Boutons via MET Coactivation.
    Frias CP; Liang J; Bresser T; Scheefhals L; van Kesteren M; van Dorland R; Hu HY; Bodzeta A; van Bergen En Henegouwen PMP; Hoogenraad CC; Wierenga CJ
    J Neurosci; 2019 May; 39(22):4221-4237. PubMed ID: 30914448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic and extrasynaptic location of the receptor tyrosine kinase met during postnatal development in the mouse neocortex and hippocampus.
    Eagleson KL; Milner TA; Xie Z; Levitt P
    J Comp Neurol; 2013 Oct; 521(14):3241-59. PubMed ID: 23787772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-synaptic function of the autism spectrum disorder-associated gene SYNGAP1 in cortical neurogenesis.
    Birtele M; Del Dosso A; Xu T; Nguyen T; Wilkinson B; Hosseini N; Nguyen S; Urenda JP; Knight G; Rojas C; Flores I; Atamian A; Moore R; Sharma R; Pirrotte P; Ashton RS; Huang EJ; Rumbaugh G; Coba MP; Quadrato G
    Nat Neurosci; 2023 Dec; 26(12):2090-2103. PubMed ID: 37946050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved subcortical and divergent cortical expression of proteins encoded by orthologs of the autism risk gene MET.
    Judson MC; Amaral DG; Levitt P
    Cereb Cortex; 2011 Jul; 21(7):1613-26. PubMed ID: 21127014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic
    Song JM; Kang M; Park DH; Park S; Lee S; Suh YH
    J Neurosci; 2021 Mar; 41(11):2344-2359. PubMed ID: 33500274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the TBR1 interactome: variants associated with neurodevelopmental disorders disrupt novel protein interactions.
    Sollis E; den Hoed J; Quevedo M; Estruch SB; Vino A; Dekkers DHW; Demmers JAA; Poot R; Deriziotis P; Fisher SE
    Hum Mol Genet; 2023 Apr; 32(9):1497-1510. PubMed ID: 36579832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders.
    Nguyen HT; Bryois J; Kim A; Dobbyn A; Huckins LM; Munoz-Manchado AB; Ruderfer DM; Genovese G; Fromer M; Xu X; Pinto D; Linnarsson S; Verhage M; Smit AB; Hjerling-Leffler J; Buxbaum JD; Hultman C; Sklar P; Purcell SM; Lage K; He X; Sullivan PF; Stahl EA
    Genome Med; 2017 Dec; 9(1):114. PubMed ID: 29262854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.